The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty

Skedgel, Chris; Goeree, Ron; Pleasance, Sue; Thompson, Kara; O'Brien, Bernie; Anderson, David
April 2007
Journal of Bone & Joint Surgery, American Volume;Apr2007, Vol. 89-A Issue 4, p819
Academic Journal
Background: Although the risk of thromboembolism after total hip arthroplasty continues beyond hospital discharge, the cost-effectiveness of extending prophylaxis beyond hospitalization is unclear. We compared the cost-effectiveness of an extended duration of antithrombotic prophylaxis following total hip arthroplasty, with use of low-molecular-weight heparin or warfarin administered for twenty-eight days beyond hospital discharge, in terms of incremental cost per quality-adjusted life year gained. Methods: The economic analysis was structured around a decision tree characterizing the consequences of extended prophylaxis choices following total hip arthroplasty. The health benefits of extended antithrombotic prophylaxis, measured as the reduction in symptomatic venous thromboembolic events and deaths for each treatment alternative, were determined through a systematic review of the literature. Gains in quality-adjusted life years were based on the distribution of life years remaining for all patients undergoing total hip arthroplasty in Canada in 2003, weighted by utilities derived from the literature. The cost analysis, in 2006 Canadian dollars, took a direct payer perspective with a ninety-day time horizon. Results: There was a net gain in quality-adjusted life years in both cohorts that received extended prophylaxis relative to the cohort that received no extended prophylaxis (7.5 quality-adjusted life years per 1000 patients treated with low-molecular-weight heparin and 5.5 quality-adjusted life years per 1000 patients treated with warfarin), although these gains were not significant. The net treatment costs per 1000 patients treated were $799,104 with low-molecular-weight heparin and $72,236 with warfarin. In comparison with the cohort that received no extended prophylaxis, the cost-effectiveness of low-molecular-weight heparin was $106,454 per quality-adjusted life year gained and the cost-effectiveness of warfarin was $13,115 per quality-adjusted life year gained. Conclusions: There is insufficient economic evidence to support extended thromboprophylaxis with low-molecular-weight heparin following total hip arthroplasty. Although the cost-effectiveness of warfarin was potentially quite favorable, this finding was based on limited clinical evidence. Further research is required to clarify the benefits of extended prophylaxis, particularly with warfarin.


Related Articles

  • The consequences of early discharge after hip arthroplasty for patient outcomes and health care costs: comparison of three centres with differing durations of stay.  // Advances in Orthopaedics;Jun2010, Vol. 2 Issue 2, p69 

    In this prospective cohort study, the authors demonstrated that a center with a rapid discharge policy after total hip arthroplasty did not have inferior outcomes compared with units with a traditional, longer stay policy.

  • Anti-Phospholipid Antibodies in Patients Undergoing Total Joint Replacement Surgery. Simpson, Melissa; Sanfelippo, Michael J.; Onitilo, Adedayo A.; Burmester, James K.; Hocking, William; Yale, Steven H.; Mazza, Joseph J. // Thrombosis;2012, p1 

    Background. Patients undergoing joint replacement remain at increased risk for venous thromboembolism (VTE) compared to other types of surgery, regardless of thromboprophylactic regimen. The pathophysiologic processes rendering this group of patients at risk for VTE are multifactorial....

  • Influence of intra-operative parameters on postoperative early recovery of active knee flexion in posterior-stabilized total knee arthroplasty. Nagai, Kanto; Muratsu, Hirotsugu; Matsumoto, Tomoyuki; Maruo, Akihiro; Miya, Hidetoshi; Kuroda, Ryosuke; Kurosaka, Masahiro // International Orthopaedics;Nov2013, Vol. 37 Issue 11, p2153 

    Purpose: Active knee flexion is more important for daily activities than passive knee flexion. The hypothesis is that the intra-operative parameters such as osteotomized bone thickness and soft tissue balance affect the postoperative active flexion angle in total knee arthroplasty (TKA)....

  • Zweymueller with metal-on-metal articulation: clinical, radiological and histological analysis of short-term results. Korovessis, Panagiotis; Petsinis, Georgios; Repanti, Maria // Archives of Orthopaedic & Trauma Surgery;Mar2003, Vol. 123 Issue 1, p5 

    Background. This is a prospective study. Methods. A total of 266 consecutive patients, who received 350 third-generation Zweymueller-SL total hip arthroplasties with metal-on-metal articulation for primary or secondary osteoarthritis, was followed and evaluated clinically, radiologically and...

  • Comparing patient outcomes after THA and TKA: is there a difference?  // Advances in Orthopaedics;Sep2010, Vol. 2 Issue 3, p116 

    The findings of this study suggest that patients undergoing primary total hip arthroplasty have better clinical outcomes than patients undergoing primary total knee arthroplasty at 1-year follow-up.

  • TOTAL HIP ARTHROPLASTY THROUGH A MINIMALLY INVASIVE ANTERIOR SURGICAL APPROACH. Kennon, Robert E.; Keggi, John M.; Wetmore, Robert S.; Zatorski, Laurine E.; Huo, Michael H.; Keggi, Kristaps J. // Journal of Bone & Joint Surgery, American Volume;Nov2003 Supplement 4, Vol. 85-A, p39 

    The article presents a study on the minimally invasive anterior approach for total hip arthroplasty. Such approach provides access to the hip through a small skin incision and secondary incisions for the acetabular and femoral instruments. The researchers believe that the minimally invasive...

  • Standard transgluteal versus minimal invasive anterior approach in hip arthroplasty: a prospective, consecutive cohort study. Ilchmann, Thomas; Gersbach, Silke; Zwicky, Lukas; Clauss, Martin // Orthopedic Reviews;2013, Vol. 5 Issue 4, p133 

    A minimally invasive anterior approach (MIS) was compared to a standard lateral approach in primary total hip arthroplasty. Clinical and radiological outcomes were analyzed 6 weeks, 12 weeks, one year and two years after surgery. The duration of surgery was longer, mobility one week after...

  • What's New in Total Hip Arthroplasty. Huo, Michael H.; Gilbert, Nathan F.; Parvizi, Javad // Journal of Bone & Joint Surgery, American Volume;Aug2007, Vol. 89-A Issue 8, p1874 

    The article discusses various reports published within the issue, including one about the total hip arthroplasty cases among eight million hospital discharge records and another about the comorbidities of hip arthroplasty.

  • Clinical pathways improve joint replacement outcomes.  // Medical Device Daily;8/9/2009, p1 

    This article discusses research being done on the benefits of organizational strategies known as clinical pathways. It references a study by Antonella Barbieri et al., published in the journal "BMC Medicine" in 2009. The study showed the efficacy of clinical pathways in improving the quality of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics